Shafaqna English– Global drugmakers, who are facing opposition from European governments over drug pricing, are now employing a strategy that recently proved effective in Britain: threatening to cancel investment and expansion plans in order to pressure policymakers.
The pharmaceutical industry is now training its sights on Germany, where a legislative proposal aimed at curbing medicine spending is under review. The sector scored a win in Britain after the government agreed to raise pharmaceutical spending as part of a deal to sidestep U.S. tariffs.
Source: Reuters